Q2 2016
Released Aug 8, 2016, before the open
10-Q filed Aug 8, 2016, 39 days after period end · 0001493152-16-012065
Q2 2016 · 10-Q
Revenue$509.00K$509.00K −10.2% vs Q2 2015−13.7% vs Q1 2016
Net Income-$835.00K-$835.00K N/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$0.02-$0.02 N/M vs Q2 2015N/M vs Q1 2016
Gross Profit$297,000−17.0%
Operating Income-$817,000N/M
Operating Cash Flowderived-$272,000N/M
Free Cash Flowderived-$286,000—
Margins · derived
Gross margin58.3%−4.8 pt vs Q2 2015
Operating margin-160.5%−55.7 pt vs Q2 2015
Net margin-164.0%+156.1 pt vs Q2 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $509.00K | $567.00K | $441.00K | $575.00K |
| Net Income | -$835.00K | -$1.82M | -$5.34M | -$1.28M |
| EPS Diluted | -$0.02 | -$0.06 | -$0.21 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR